Niche antibody expertise QED Bioscience is a long‑standing antibody design and manufacturing specialist with over 20 years in the field, offering monoclonal and polyclonal products plus immunochemistry services. This deep specialization suggests sales opportunities around custom antibody development, conjugation, purification, and target customization for academic, biotech, diagnostic, and pharma customers.

Full‑service capabilities The company positions itself as a full‑service antibody supplier, handling development to final product with services such as purification and conjugation. Potential upsell exists for clients needing end‑to‑end workflows, including characterization, pharmacological activity engineering, and anti‑idiotypic antibodies.

Targeted market fit Current offerings emphasize collaboration around client targets (small molecules, proteins, peptides, or cDNA) which aligns with researchers needing tailored antibodies for niche assays, diagnostics, or therapeutic research. This creates sales opportunities in academic collaborations and biotech programs requiring customized antibody solutions.

Growth through personalization With a lean team and revenue in the low millions, there is room to scale via targeted account-based outreach to mid‑size biotech, diagnostics, and pharma research labs seeking specialized antibodies and related services, leveraging the firm’s customization capabilities.

Competitive positioning Positioning against larger CROs and suppliers can be reinforced by highlighting specialization, bespoke antibody development, and pharmacological activity antibodies. Emphasize speed, flexibility, and client‑centric service to win projects where large vendors lack agility.